• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

额颞叶变性伴 TAR DNA 结合蛋白 43(TDP-43):跨越百年的历程。

Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.

机构信息

Department of Neurology, Mayo Clinic, 200 1st St S.W, Rochester, MN, 55905, USA.

出版信息

J Neurol. 2022 Aug;269(8):4030-4054. doi: 10.1007/s00415-022-11073-3. Epub 2022 Mar 23.

DOI:10.1007/s00415-022-11073-3
PMID:35320398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10184567/
Abstract

Frontotemporal lobar degeneration (FTLD) with TDP-43-immunoreactive inclusions (FTLD-TDP) is a neurodegenerative disease associated with clinical, genetic, and neuropathological heterogeneity. An association between TDP-43, FTLD and amyotrophic lateral sclerosis (ALS) was first described in 2006. However, a century before immunohistochemistry existed, atypical dementias displaying behavioral, language and/or pyramidal symptoms and showing non-specific FTLD with superficial cortical neuronal loss, gliosis and spongiosis were often confused with Alzheimer's or Pick's disease. Initially this pathology was termed dementia lacking distinctive histopathology (DLDH), but this was later renamed when ubiquitinated inclusions originally found in ALS were also discovered in (DLDH), thus warranting a recategorization as FTLD-U (ubiquitin). Finally, the ubiquitinated protein was identified as TDP-43, which aggregates in cortical, subcortical, limbic and brainstem neurons and glial cells. The topography and morphology of TDP-43 inclusions associate with specific clinical syndromes and genetic mutations which implies different pathomechanisms that are yet to be discovered; hence, the TDP-43 journey has actually just begun. In this review, we describe how FTLD-TDP was established and defined clinically and neuropathologically throughout the past century.

摘要

额颞叶变性(FTLD)伴 TDP-43 免疫反应性包含物(FTLD-TDP)是一种与临床、遗传和神经病理学异质性相关的神经退行性疾病。TDP-43、FTLD 和肌萎缩侧索硬化症(ALS)之间的关联于 2006 年首次被描述。然而,在免疫组织化学出现之前的一个世纪,表现出行为、语言和/或锥体症状的非典型痴呆症,以及显示非特异性 FTLD 伴有皮质浅层神经元丢失、神经胶质增生和海绵状变性,常与阿尔茨海默病或皮克病混淆。最初,这种病理学被称为缺乏特征性组织病理学的痴呆症(DLDH),但后来当在 ALS 中最初发现的泛素化包含物也被发现时,它被重新命名为 FTLD-U(泛素)。最后,鉴定出聚集在皮质、皮质下、边缘和脑干神经元和神经胶质细胞中的泛素化蛋白为 TDP-43。TDP-43 包含物的拓扑结构和形态与特定的临床综合征和遗传突变相关,这表明存在尚未发现的不同病理机制;因此,TDP-43 的研究实际上才刚刚开始。在这篇综述中,我们描述了在过去的一个世纪中,FTLD-TDP 是如何在临床和神经病理学上被确立和定义的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb01/10184567/e731e35bca03/nihms-1891599-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb01/10184567/fd9723117977/nihms-1891599-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb01/10184567/c420cb07a795/nihms-1891599-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb01/10184567/e731e35bca03/nihms-1891599-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb01/10184567/fd9723117977/nihms-1891599-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb01/10184567/c420cb07a795/nihms-1891599-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb01/10184567/e731e35bca03/nihms-1891599-f0003.jpg

相似文献

1
Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.额颞叶变性伴 TAR DNA 结合蛋白 43(TDP-43):跨越百年的历程。
J Neurol. 2022 Aug;269(8):4030-4054. doi: 10.1007/s00415-022-11073-3. Epub 2022 Mar 23.
2
Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.伴有和不伴肌萎缩性侧索硬化的额颞叶变性中 TDP-43 包涵体的不同形态。
Acta Neuropathol Commun. 2017 Oct 27;5(1):76. doi: 10.1186/s40478-017-0480-2.
3
The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.RNA 结合基序 45(RBM45)蛋白在肌萎缩侧索硬化症(ALS)和伴有 TDP-43 包涵体的额颞叶变性(FTLD-TDP)患者中积聚在包涵体中。
Acta Neuropathol. 2012 Nov;124(5):717-32. doi: 10.1007/s00401-012-1045-x. Epub 2012 Sep 21.
4
Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.基于数据的 TDP-43 蛋白病神经病理学分期和亚型分类。
Brain. 2023 Jul 3;146(7):2975-2988. doi: 10.1093/brain/awad145.
5
TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.TDP-43 在散发型和关岛肌萎缩侧索硬化症中与泛素化包涵体一致共存,但在伴有和不伴有 SOD1 突变的家族性肌萎缩侧索硬化症中则没有。
Neuropathology. 2009 Dec;29(6):672-83. doi: 10.1111/j.1440-1789.2009.01029.x. Epub 2009 Jun 3.
6
Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.TAR DNA 结合蛋白 43kDa 相关的额颞叶痴呆和肌萎缩性侧索硬化症中的下运动神经元受累。
JAMA Neurol. 2014 Feb;71(2):172-9. doi: 10.1001/jamaneurol.2013.5489.
7
Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies.载脂蛋白 A11 聚集与 FTLD-TDP 型 C 及相关神经退行性疾病蛋白病。
Acta Neuropathol. 2024 Jun 19;147(1):104. doi: 10.1007/s00401-024-02753-7.
8
Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.皮克病与伴有泛素/TDP-43阳性包涵体的额颞叶痴呆的临床病理特征
Acta Neuropathol. 2009 Apr;117(4):429-44. doi: 10.1007/s00401-009-0493-4. Epub 2009 Feb 5.
9
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.TDP-43 转基因小鼠出现痉挛性瘫痪和神经元包含物,具有 ALS 和额颞叶变性的特征。
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3858-63. doi: 10.1073/pnas.0912417107. Epub 2010 Feb 3.
10
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.TDP - 43突变转基因小鼠出现肌萎缩侧索硬化症和额颞叶痴呆的症状。
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18809-14. doi: 10.1073/pnas.0908767106. Epub 2009 Oct 15.

引用本文的文献

1
RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights.肌萎缩侧索硬化症和额颞叶痴呆中的RNA结合蛋白:从致病机制到治疗见解
Mol Neurodegener. 2025 Jun 4;20(1):64. doi: 10.1186/s13024-025-00851-y.
2
Safety and Efficacy of Different Therapeutic Interventions for Primary Progressive Aphasia: A Systematic Review.原发性进行性失语不同治疗干预措施的安全性与有效性:一项系统评价
J Clin Med. 2025 Apr 29;14(9):3063. doi: 10.3390/jcm14093063.
3
Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1-indoles as Tauopathy Positron Emission Tomography Radiotracers.

本文引用的文献

1
Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance.额颞叶变性 TDP-43 免疫反应性病理亚型:临床和机制意义。
Adv Exp Med Biol. 2021;1281:201-217. doi: 10.1007/978-3-030-51140-1_13.
2
The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.TDP-43 蛋白病临床病理异质性的基础。
Acta Neuropathol. 2019 Nov;138(5):751-770. doi: 10.1007/s00401-019-02077-x. Epub 2019 Sep 26.
3
Subcortical TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases.
2-(杂芳基-环烷基)-1-吲哚作为tau蛋白病正电子发射断层显像剂的构效关系及评价
J Med Chem. 2025 Mar 27;68(6):6462-6492. doi: 10.1021/acs.jmedchem.4c02988. Epub 2025 Mar 11.
4
Volumetric analysis of hippocampal subregions and subfields in left and right semantic dementia.左右侧语义性痴呆中海马亚区和亚组的容积分析
Brain Commun. 2024 Mar 25;6(2):fcae097. doi: 10.1093/braincomms/fcae097. eCollection 2024.
5
Comprehensive analysis of co-expressed genes with TDP-43: prognostic and therapeutic potential in lung adenocarcinoma.全面分析与 TDP-43 共表达的基因:肺腺癌的预后和治疗潜力。
J Cancer Res Clin Oncol. 2024 Jan 28;150(2):44. doi: 10.1007/s00432-023-05554-9.
6
Sleep matters: Neurodegeneration spectrum heterogeneity, combustion and friction ultrafine particles, industrial nanoparticle pollution, and sleep disorders-Denial is not an option.睡眠至关重要:神经退行性变谱的异质性、燃烧与摩擦产生的超细颗粒、工业纳米颗粒污染以及睡眠障碍——否认并非可行之策。
Front Neurol. 2023 Feb 27;14:1117695. doi: 10.3389/fneur.2023.1117695. eCollection 2023.
7
Necroptosis in CNS diseases: Focus on astrocytes.中枢神经系统疾病中的坏死性凋亡:聚焦于星形胶质细胞。
Front Aging Neurosci. 2023 Jan 27;14:1016053. doi: 10.3389/fnagi.2022.1016053. eCollection 2022.
8
TDP-43 and NEAT long non-coding RNA: Roles in neurodegenerative disease.TDP-43与NEAT长链非编码RNA:在神经退行性疾病中的作用
Front Cell Neurosci. 2022 Oct 26;16:954912. doi: 10.3389/fncel.2022.954912. eCollection 2022.
9
Cognitive and behavioral involvement in ALS has been known for more than a century.肌萎缩侧索硬化症的认知和行为参与已经有一个多世纪的历史了。
Neurol Sci. 2022 Dec;43(12):6741-6760. doi: 10.1007/s10072-022-06340-0. Epub 2022 Sep 2.
皮质下 TDP-43 病理学模式验证了皮质额颞叶变性-TDP 亚型,并显示了 C9orf72 突变病例的独特方面。
Acta Neuropathol. 2020 Jan;139(1):83-98. doi: 10.1007/s00401-019-02070-4. Epub 2019 Sep 9.
4
FTD spectrum: Neuroimaging across the FTD spectrum.额颞叶痴呆谱:额颞叶痴呆谱中的神经影像学。
Prog Mol Biol Transl Sci. 2019;165:187-223. doi: 10.1016/bs.pmbts.2019.05.009. Epub 2019 Jun 18.
5
LATE to the PART-y.赶派对迟到了。
Brain. 2019 Sep 1;142(9):e47. doi: 10.1093/brain/awz224.
6
C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation.TDP-43 的 C 端和全长异构体根据 FTLD-TDP 病变类型而有所不同,但与基因突变无关。
Acta Neuropathol Commun. 2019 Jul 2;7(1):100. doi: 10.1186/s40478-019-0755-x.
7
Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes.重新审视TDP-43免疫反应性(TDP-43-ir)病理学在对额颞叶痴呆-TDP亚型进行分类中的作用。
Acta Neuropathol. 2019 Jul;138(1):167-169. doi: 10.1007/s00401-019-02024-w. Epub 2019 May 7.
8
The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability.未被充分认识的 PPA-ALS:具有强遗传性的独特临床病理亚型。
Neurology. 2019 Mar 19;92(12):e1354-e1366. doi: 10.1212/WNL.0000000000007146. Epub 2019 Feb 15.
9
Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.皮质基底节变性伴 TDP-43 病理学表现为进行性核上性麻痹综合征:一种独特的临床病理亚型。
Acta Neuropathol. 2018 Sep;136(3):389-404. doi: 10.1007/s00401-018-1878-z. Epub 2018 Jun 20.
10
Reappraisal of TDP-43 pathology in FTLD-U subtypes.重新评估 FTLD-U 亚型中的 TDP-43 病理学。
Acta Neuropathol. 2017 Jul;134(1):79-96. doi: 10.1007/s00401-017-1716-8. Epub 2017 May 2.